10 citations as recorded by crossref.

1. Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review K. Tsegka et al. https://doi.org/10.1080/14787210.2021.1932463
2. Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review R. Antonello et al. https://doi.org/10.1093/jac/dkac346
3. Emerging Concepts for the Treatment of Biofilm-Associated Bone and Joint Infections with IV Fosfomycin: A Literature Review S. Tedeschi et al. https://doi.org/10.3390/microorganisms13050963
4. Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections? P. Cojutti et al. https://doi.org/10.3390/antibiotics14020139
5. Prótesis total de fémur en pacientes no oncológicos G. Luengo-Alonso et al. https://doi.org/10.35366/101864
6. Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice M. Gatti et al. https://doi.org/10.3390/antibiotics11030406
7. Antibiotics with antibiofilm activity – rifampicin and beyond L. Ferreira et al. https://doi.org/10.3389/fmicb.2024.1435720
8. Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections G. Pipitone et al. https://doi.org/10.3390/antibiotics12121653
9. Probing fosfomycin’s potential: a study on susceptibility testing and resistance in Staphylococcus epidermidis from prosthetic joint infections R. Widerström et al. https://doi.org/10.1093/jac/dkae312
10. Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach M. Gatti et al. https://doi.org/10.1080/17425255.2023.2255525